Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Bruno Sepodes

The Power List 2018 – Champions of Change


Bruno Sepodes

Professor of Pharmacology and Pharmacotherapy, University of Lisbon; Chair of the EMA Committee of Orphan Medicinal Products

After studying pharmacy at university and then moving into toxicology, Bruno became an assessor for the Portuguese medicine regulator INFARMED before moving to the European Medicines Agency. From there, he developed a passion for the regulation of orphan diseases, creating incentives for development and therefore improving public health. He recently received the EURORDIS Rare Disease Leadership Award. “I would like to see a better and earlier dialogue with regulators in order for drug development to be as smooth as possible. There are still several missed opportunities of interaction with regulators and we simply cannot afford that, especially in some fields such as drug development for rare diseases,” says Bruno.


Part of the Power List 2018

The World’s Top 100 Medicine Makers

Bringing new drugs to patients is an incredibly difficult task that involves numerous indispensable actors – from pioneering entrepreneurs and CEOs, to industry experts, to dedicated researchers, to regulators who keep everyone on the right tracks.

Go to The Power List 2018

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register